Compare CARS & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CARS | HQL |
|---|---|---|
| Founded | 1998 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Motor Vehicles | Investment Managers |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 476.1M | 507.9M |
| IPO Year | 2017 | N/A |
| Metric | CARS | HQL |
|---|---|---|
| Price | $10.09 | $17.83 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 106.9K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.32 | ★ 0.79 |
| Revenue | ★ $723,239,000.00 | N/A |
| Revenue This Year | $2.97 | N/A |
| Revenue Next Year | $2.48 | N/A |
| P/E Ratio | $31.58 | ★ $22.49 |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $7.40 | $11.72 |
| 52 Week High | $13.97 | $17.85 |
| Indicator | CARS | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 68.89 | 68.73 |
| Support Level | $7.88 | $16.40 |
| Resistance Level | $13.66 | N/A |
| Average True Range (ATR) | 0.38 | 0.36 |
| MACD | 0.28 | 0.15 |
| Stochastic Oscillator | 92.72 | 94.39 |
Cars.com Inc is an audience-powered and data-driven technology platform that simplifies buying and selling cars. The flagship Cars.com marketplace connects consumers to dealerships across the U.S., powering the car-buying experience with artificial intelligence (AI) shopping tools, vehicle reviews and content. Its ecosystem of products enables dealers and OEMs to sell more cars by leveraging the marketplace, dealer websites, trade and appraisal tools and proprietary in-market media solutions. The platform provides shoppers with data, resources and digital tools to make informed buying decisions and connect with automotive retailers. The Company also provides dealerships and OEMs with solutions and data-driven intelligence to reach and influence its 26 million monthly shoppers.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.